16 research outputs found

    PLOS Pathogens publication: A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates.

    No full text
    Tuberculosis (TB) causes more deaths than any other single infectious disease, and a new, improved vaccine is needed to control the epidemic. Many new TB vaccine candidates are in clinical development, but only one or two can be advanced to expensive efficacy trials. In this study, we compared magnitude and functional attributes of memory T cell responses induced in recently conducted clinical trials by six TB vaccine candidates, as well as BCG. The results suggest that these vaccines induced CD4 and CD8 T cellresponses with similar functional attributes, but that one vaccine, M72/AS01 E , induced the largest responses. This finding may indicate a lack of diversity in T cell responses induced by different TB vaccine candidates. A repertoire of vaccine candidates that induces more diverse immune response characteristics may increase the chances of finding a protective vaccine against TB.</div

    Vaccines

    No full text
    The dataset (Vaccines) contains background subtracted frequencies of CD4 and CD8 T cells producing a combination of IFNγ, IL-2, TNF and IL-17 in response to stimulation by vaccine-specific antigens for the vaccines included in the paper "A head-to-head comparison of specific T cell responses induced by six novel tuberculosis vaccine candidates". See paper for details. See Column names - Vaccines.docx for meanings of column names in the dataset (Vaccines)

    A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates (BioRxiv preprint)

    No full text
    Pre-print submitted to BioRxiv.Abstract: Eradication of tuberculosis (TB), the world's leading cause of death due to infectious disease, requires a highly efficacious TB vaccine. Many TB vaccine candidates are in pre-clinical and clinical development but only a few can be advanced to large - scale efficacy trials due to limited global resources. We aimed to perform a statistically rigorous comparison of the antigen - specific T cell responses induced by six novel TB vaccine candidates and the only licensed TB vaccine, Bacillus Calmette - Guérin (BCG). We propose that the antigen - specific immune response induced by such vaccines provides an objective, data - driven basis for prioritisation of vaccine candidates for efficacy testing. We analyze d frequencies of antigen - specific CD4 and CD8 T cells expressing IFN γ, IL - 2, TNF and/or IL - 17 from adolescents or adults, with or without Mycobacterium tuberculosis ( M.tb ) infection, who received MVA85A, A ERAS - 402, H1:IC31, H56:IC31, M72/AS01 E, ID93 + GLA - SE or BCG. Two key response characteristics were analyzed, namely response magnitude and cytokine co - expression profile of the memory T cell response that persisted above the pre-vaccination response to the final study visit in each trial. All vaccines preferentially induced antigen - specific CD4 T cell responses expressing Th1 cytokines; levels of IL - 17 - expressing cells were low or not detected. In M.tb - uninfected and - infected individuals, M72/AS01 E induced higher memory Th1 cytokine - expressing CD4 T cell response s than other novel vaccine candidates. Cytokine co - expression profile s of memory CD4 T cells induced by different novel vaccine candidates were alike. Our study suggests that the T cell response feature which most differentiated between the TB vaccine candidates was response magnitude, whilst functional profiles suggested a lack of response diversity. Since M72/AS01 E induced the highest memory CD4 T cell response it demonstrated the best vaccine take. In the absence of immunological correlates of protection the likelihood of finding a protective vaccine by empirical testing of candidates may be increased by the addition of candidates that induce distinct immune characteristics. <br

    Megapool

    No full text
    This dataset (Megapool) contains background subtracted frequencies of CD4 and CD8 T cells producing a combination of IFNγ, IL-2 and TNF in response to stimulation by Megapool for Mtb-infected but healthy individuals (Lindestam Arlehamn, 2016). See referenced paper for details. See Column names - Megapool.docx for meanings of column names in Megapool.xlsx.<br

    image_3.PDF

    No full text
    Background<p>Maintenance of long-lasting immunity is thought to depend on stem cell memory T cells (T<sub>SCM</sub>), which have superior self-renewing capacity, longevity and proliferative potential compared with central memory (T<sub>CM</sub>) or effector (T<sub>EFF</sub>) T cells. Our knowledge of T<sub>SCM</sub> derives primarily from studies of virus-specific CD8<sup>+</sup> T<sub>SCM</sub>. We aimed to determine if infection with Mycobacterium tuberculosis (M. tb), the etiological agent of tuberculosis, generates antigen-specific CD4<sup>+</sup> T<sub>SCM</sub> and to characterize their functional ontology.</p>Methods<p>We studied T cell responses to natural M. tb infection in a longitudinal adolescent cohort of recent QuantiFERON-TB Gold (QFT) converters and three cross-sectional QFT<sup>+</sup> adult cohorts; and to bacillus Calmette–Guerin (BCG) vaccination in infants. M. tb and/or BCG-specific CD4 T cells were detected by flow cytometry using major histocompatibility complex class II tetramers bearing Ag85, CFP-10, or ESAT-6 peptides, or by intracellular cytokine staining. Transcriptomic analyses of M. tb-specific tetramer<sup>+</sup> CD4<sup>+</sup> T<sub>SCM</sub> (CD45RA<sup>+</sup> CCR7<sup>+</sup> CD27<sup>+</sup>) were performed by microfluidic qRT-PCR, and functional and phenotypic characteristics were confirmed by measuring expression of chemokine receptors, cytotoxic molecules and cytokines using flow cytometry.</p>Results<p>M. tb-specific T<sub>SCM</sub> were not detected in QFT-negative persons. After QFT conversion frequencies of T<sub>SCM</sub> increased to measurable levels and remained detectable thereafter, suggesting that primary M. tb infection induces T<sub>SCM</sub> cells. Gene expression (GE) profiling of tetramer<sup>+</sup> T<sub>SCM</sub> showed that these cells were distinct from bulk CD4<sup>+</sup> naïve T cells (T<sub>N</sub>) and shared features of bulk T<sub>SCM</sub> and M. tb-specific tetramer<sup>+</sup> T<sub>CM</sub> and T<sub>EFF</sub> cells. These T<sub>SCM</sub> were predominantly CD95<sup>+</sup> and CXCR3<sup>+</sup>, markers typical of CD8<sup>+</sup> T<sub>SCM</sub>. Tetramer<sup>+</sup> T<sub>SCM</sub> expressed significantly higher protein levels of CCR5, CCR6, CXCR3, granzyme A, granzyme K, and granulysin than bulk T<sub>N</sub> and T<sub>SCM</sub> cells. M. tb-specific T<sub>SCM</sub> were also functional, producing IL-2, IFN-γ, and TNF-α upon antigen stimulation, and their frequencies correlated positively with long-term BCG-specific CD4<sup>+</sup> T cell proliferative potential after infant vaccination.</p>Conclusion<p>Human infection with M. tb induced distinct, antigen-specific CD4<sup>+</sup> T<sub>SCM</sub> cells endowed with effector functions, including expression of cytotoxic molecules and Th1 cytokines, and displayed chemokine receptor profiles consistent with memory Th1/17 cells. Induction of CD4<sup>+</sup> T<sub>SCM</sub> should be considered for vaccination approaches that aim to generate long-lived memory T cells against M. tb.</p

    Table_1.PDF

    No full text
    Background<p>Maintenance of long-lasting immunity is thought to depend on stem cell memory T cells (T<sub>SCM</sub>), which have superior self-renewing capacity, longevity and proliferative potential compared with central memory (T<sub>CM</sub>) or effector (T<sub>EFF</sub>) T cells. Our knowledge of T<sub>SCM</sub> derives primarily from studies of virus-specific CD8<sup>+</sup> T<sub>SCM</sub>. We aimed to determine if infection with Mycobacterium tuberculosis (M. tb), the etiological agent of tuberculosis, generates antigen-specific CD4<sup>+</sup> T<sub>SCM</sub> and to characterize their functional ontology.</p>Methods<p>We studied T cell responses to natural M. tb infection in a longitudinal adolescent cohort of recent QuantiFERON-TB Gold (QFT) converters and three cross-sectional QFT<sup>+</sup> adult cohorts; and to bacillus Calmette–Guerin (BCG) vaccination in infants. M. tb and/or BCG-specific CD4 T cells were detected by flow cytometry using major histocompatibility complex class II tetramers bearing Ag85, CFP-10, or ESAT-6 peptides, or by intracellular cytokine staining. Transcriptomic analyses of M. tb-specific tetramer<sup>+</sup> CD4<sup>+</sup> T<sub>SCM</sub> (CD45RA<sup>+</sup> CCR7<sup>+</sup> CD27<sup>+</sup>) were performed by microfluidic qRT-PCR, and functional and phenotypic characteristics were confirmed by measuring expression of chemokine receptors, cytotoxic molecules and cytokines using flow cytometry.</p>Results<p>M. tb-specific T<sub>SCM</sub> were not detected in QFT-negative persons. After QFT conversion frequencies of T<sub>SCM</sub> increased to measurable levels and remained detectable thereafter, suggesting that primary M. tb infection induces T<sub>SCM</sub> cells. Gene expression (GE) profiling of tetramer<sup>+</sup> T<sub>SCM</sub> showed that these cells were distinct from bulk CD4<sup>+</sup> naïve T cells (T<sub>N</sub>) and shared features of bulk T<sub>SCM</sub> and M. tb-specific tetramer<sup>+</sup> T<sub>CM</sub> and T<sub>EFF</sub> cells. These T<sub>SCM</sub> were predominantly CD95<sup>+</sup> and CXCR3<sup>+</sup>, markers typical of CD8<sup>+</sup> T<sub>SCM</sub>. Tetramer<sup>+</sup> T<sub>SCM</sub> expressed significantly higher protein levels of CCR5, CCR6, CXCR3, granzyme A, granzyme K, and granulysin than bulk T<sub>N</sub> and T<sub>SCM</sub> cells. M. tb-specific T<sub>SCM</sub> were also functional, producing IL-2, IFN-γ, and TNF-α upon antigen stimulation, and their frequencies correlated positively with long-term BCG-specific CD4<sup>+</sup> T cell proliferative potential after infant vaccination.</p>Conclusion<p>Human infection with M. tb induced distinct, antigen-specific CD4<sup>+</sup> T<sub>SCM</sub> cells endowed with effector functions, including expression of cytotoxic molecules and Th1 cytokines, and displayed chemokine receptor profiles consistent with memory Th1/17 cells. Induction of CD4<sup>+</sup> T<sub>SCM</sub> should be considered for vaccination approaches that aim to generate long-lived memory T cells against M. tb.</p

    image_1.PDF

    No full text
    Background<p>Maintenance of long-lasting immunity is thought to depend on stem cell memory T cells (T<sub>SCM</sub>), which have superior self-renewing capacity, longevity and proliferative potential compared with central memory (T<sub>CM</sub>) or effector (T<sub>EFF</sub>) T cells. Our knowledge of T<sub>SCM</sub> derives primarily from studies of virus-specific CD8<sup>+</sup> T<sub>SCM</sub>. We aimed to determine if infection with Mycobacterium tuberculosis (M. tb), the etiological agent of tuberculosis, generates antigen-specific CD4<sup>+</sup> T<sub>SCM</sub> and to characterize their functional ontology.</p>Methods<p>We studied T cell responses to natural M. tb infection in a longitudinal adolescent cohort of recent QuantiFERON-TB Gold (QFT) converters and three cross-sectional QFT<sup>+</sup> adult cohorts; and to bacillus Calmette–Guerin (BCG) vaccination in infants. M. tb and/or BCG-specific CD4 T cells were detected by flow cytometry using major histocompatibility complex class II tetramers bearing Ag85, CFP-10, or ESAT-6 peptides, or by intracellular cytokine staining. Transcriptomic analyses of M. tb-specific tetramer<sup>+</sup> CD4<sup>+</sup> T<sub>SCM</sub> (CD45RA<sup>+</sup> CCR7<sup>+</sup> CD27<sup>+</sup>) were performed by microfluidic qRT-PCR, and functional and phenotypic characteristics were confirmed by measuring expression of chemokine receptors, cytotoxic molecules and cytokines using flow cytometry.</p>Results<p>M. tb-specific T<sub>SCM</sub> were not detected in QFT-negative persons. After QFT conversion frequencies of T<sub>SCM</sub> increased to measurable levels and remained detectable thereafter, suggesting that primary M. tb infection induces T<sub>SCM</sub> cells. Gene expression (GE) profiling of tetramer<sup>+</sup> T<sub>SCM</sub> showed that these cells were distinct from bulk CD4<sup>+</sup> naïve T cells (T<sub>N</sub>) and shared features of bulk T<sub>SCM</sub> and M. tb-specific tetramer<sup>+</sup> T<sub>CM</sub> and T<sub>EFF</sub> cells. These T<sub>SCM</sub> were predominantly CD95<sup>+</sup> and CXCR3<sup>+</sup>, markers typical of CD8<sup>+</sup> T<sub>SCM</sub>. Tetramer<sup>+</sup> T<sub>SCM</sub> expressed significantly higher protein levels of CCR5, CCR6, CXCR3, granzyme A, granzyme K, and granulysin than bulk T<sub>N</sub> and T<sub>SCM</sub> cells. M. tb-specific T<sub>SCM</sub> were also functional, producing IL-2, IFN-γ, and TNF-α upon antigen stimulation, and their frequencies correlated positively with long-term BCG-specific CD4<sup>+</sup> T cell proliferative potential after infant vaccination.</p>Conclusion<p>Human infection with M. tb induced distinct, antigen-specific CD4<sup>+</sup> T<sub>SCM</sub> cells endowed with effector functions, including expression of cytotoxic molecules and Th1 cytokines, and displayed chemokine receptor profiles consistent with memory Th1/17 cells. Induction of CD4<sup>+</sup> T<sub>SCM</sub> should be considered for vaccination approaches that aim to generate long-lived memory T cells against M. tb.</p

    Adolescent BCG revaccination induces a phenotypic shift in CD4+ T cell responses to Mycobacterium tuberculosis

    No full text
    Abstract A recent clinical trial demonstrated that Bacille Calmette-Guérin (BCG) revaccination of adolescents reduced the risk of sustained infection with Mycobacterium tuberculosis (M.tb). In a companion phase 1b trial, HVTN 602/Aeras A-042, we characterize in-depth the cellular responses to BCG revaccination or to a H4:IC31 vaccine boost to identify T cell subsets that could be responsible for the protection observed. High-dimensional clustering analysis of cells profiled using a 26-color flow cytometric panel show marked increases in five effector memory CD4+ T cell subpopulations (TEM) after BCG revaccination, two of which are highly polyfunctional. CITE-Seq single-cell analysis shows that the activated subsets include an abundant cluster of Th1 cells with migratory potential. Additionally, a small cluster of Th17 TEM cells induced by BCG revaccination expresses high levels of CD103; these may represent recirculating tissue-resident memory cells that could provide pulmonary immune protection. Together, these results identify unique populations of CD4+ T cells with potential to be immune correlates of protection conferred by BCG revaccination

    image_4.PDF

    No full text
    Background<p>Maintenance of long-lasting immunity is thought to depend on stem cell memory T cells (T<sub>SCM</sub>), which have superior self-renewing capacity, longevity and proliferative potential compared with central memory (T<sub>CM</sub>) or effector (T<sub>EFF</sub>) T cells. Our knowledge of T<sub>SCM</sub> derives primarily from studies of virus-specific CD8<sup>+</sup> T<sub>SCM</sub>. We aimed to determine if infection with Mycobacterium tuberculosis (M. tb), the etiological agent of tuberculosis, generates antigen-specific CD4<sup>+</sup> T<sub>SCM</sub> and to characterize their functional ontology.</p>Methods<p>We studied T cell responses to natural M. tb infection in a longitudinal adolescent cohort of recent QuantiFERON-TB Gold (QFT) converters and three cross-sectional QFT<sup>+</sup> adult cohorts; and to bacillus Calmette–Guerin (BCG) vaccination in infants. M. tb and/or BCG-specific CD4 T cells were detected by flow cytometry using major histocompatibility complex class II tetramers bearing Ag85, CFP-10, or ESAT-6 peptides, or by intracellular cytokine staining. Transcriptomic analyses of M. tb-specific tetramer<sup>+</sup> CD4<sup>+</sup> T<sub>SCM</sub> (CD45RA<sup>+</sup> CCR7<sup>+</sup> CD27<sup>+</sup>) were performed by microfluidic qRT-PCR, and functional and phenotypic characteristics were confirmed by measuring expression of chemokine receptors, cytotoxic molecules and cytokines using flow cytometry.</p>Results<p>M. tb-specific T<sub>SCM</sub> were not detected in QFT-negative persons. After QFT conversion frequencies of T<sub>SCM</sub> increased to measurable levels and remained detectable thereafter, suggesting that primary M. tb infection induces T<sub>SCM</sub> cells. Gene expression (GE) profiling of tetramer<sup>+</sup> T<sub>SCM</sub> showed that these cells were distinct from bulk CD4<sup>+</sup> naïve T cells (T<sub>N</sub>) and shared features of bulk T<sub>SCM</sub> and M. tb-specific tetramer<sup>+</sup> T<sub>CM</sub> and T<sub>EFF</sub> cells. These T<sub>SCM</sub> were predominantly CD95<sup>+</sup> and CXCR3<sup>+</sup>, markers typical of CD8<sup>+</sup> T<sub>SCM</sub>. Tetramer<sup>+</sup> T<sub>SCM</sub> expressed significantly higher protein levels of CCR5, CCR6, CXCR3, granzyme A, granzyme K, and granulysin than bulk T<sub>N</sub> and T<sub>SCM</sub> cells. M. tb-specific T<sub>SCM</sub> were also functional, producing IL-2, IFN-γ, and TNF-α upon antigen stimulation, and their frequencies correlated positively with long-term BCG-specific CD4<sup>+</sup> T cell proliferative potential after infant vaccination.</p>Conclusion<p>Human infection with M. tb induced distinct, antigen-specific CD4<sup>+</sup> T<sub>SCM</sub> cells endowed with effector functions, including expression of cytotoxic molecules and Th1 cytokines, and displayed chemokine receptor profiles consistent with memory Th1/17 cells. Induction of CD4<sup>+</sup> T<sub>SCM</sub> should be considered for vaccination approaches that aim to generate long-lived memory T cells against M. tb.</p
    corecore